Katrina’s Blog™
News and Commentary
on the science and technology of drugs and medical devices, including discovery, development, manufacturing, and regulation.
NSF Research Funding to Build the American Bioeconomy – is it for you?
Executive Order 14081: Advancing Biotechnology and Biomanufacturing Innovation for a Sustainable, Safe, and Secure American Bioeconomy [1] in September 2022 marked a change in thinking about the U.S. bioeconomy. The order summarizes the situation perfectly: “The...
U.S. Strategy for Innovation – “Out Innovate With Everyone”
The National Advisory Council on Innovation and Entrepreneurship (NACIE) recently issued ten strategic recommendations for strengthening US entrepreneurship. The report highlights three critical areas: growing our future industries, accessing startup funding, and...
Outbreak – Four Years Later
March 2024 marks four years since the coronavirus outbreak and the global pandemic lockdown started. I wrote several articles spanning February – April 2020, sharing information and making some projections. This is a good time to reflect on the past and what we’ve...
Talent Acquisition and Retention is Broken!
The COVID-19 pandemic has highlighted many flaws in talent acquisition and retention strategies. Companies cannot find suitable candidates to fill positions, yet skilled individuals still need to get a callback after submitting their applications. It's taking weeks to...
The Importance of Rare Disease Research
In the U.S., a rare disease or disorder is defined as one that affects fewer than 200,000 persons. Cumulatively, more than 7,000 rare diseases affect more than 30 million Americans. [2] “As many as 95% of rare diseases have no specific treatment or curative options,”...